Yarrow Bioscience (YARW) Revenue (2016 - 2026)
Yarrow Bioscience's (YARW) quarterly Revenue came in at $86000.0 in Q1 2026, down 57.0% YoY from $200000.0 in Q1 2025, and down 14.0% on a QoQ basis from $100000.0 in Q2 2025.
Yarrow Bioscience (YARW) Revenue (2016 - 2026) Analysis & Trends
Yarrow Bioscience (YARW) has 11 years of Revenue data on file, last reported at $86000.0 in Q1 2026.
- Quarterly Revenue fell 57.0% year-over-year to $86000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $469000.0 (down 22.09% YoY) and the FY2025 annual result came in at $570000.0, up 14.0% from the prior year.
- Revenue eased to $86000.0 in Q1 2026, from $100000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $200000.0 in Q1 2025 to a low of $29000.0 in Q4 2022.
- A 5-year average of $118533.3 and a median of $100000.0 in 2023 frame the typical range for Revenue.
- Annual changes were most pronounced in 2022 — Revenue tumbled 89.38% — and 2023, when it surged 162.07%.
- Tracing YARW's Revenue over 5 years: stood at $29000.0 in 2022, then surged by 162.07% to $76000.0 in 2023, then advanced by 9.21% to $83000.0 in 2024, then grew by 20.48% to $100000.0 in 2025, then decreased by 14.0% to $86000.0 in 2026.
- The last three Revenue figures came in at $86000.0 (Q1 2026), $100000.0 (Q2 2025), and $200000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 674.14 Mn |
| 10 | Yarrow Bioscience | 31.25 Mn | 8.33 Mn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 100,000.00 |
| Mar 31, 2026 | 86,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 83,000.00 |
| Sep 30, 2024 | 121,000.00 |
| Jun 30, 2024 | 198,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 76,000.00 |
| Sep 30, 2023 | 114,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 29,000.00 |
| Sep 30, 2022 | 167,000.00 |
| Jun 30, 2022 | 126,000.00 |
| Mar 31, 2022 | 178,000.00 |
| Dec 31, 2021 | 273,000.00 |
| Sep 30, 2021 | 133,000.00 |
| Jun 30, 2021 | 295,000.00 |
| Mar 31, 2021 | 230,000.00 |